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Abstract
Background: Skin has a variety of functions that are incompletely understood at the molecular level. As the most accessible
tissue in the body it often reveals the first signs of inflammation or infection and also represents a potentially valuable
source of biomarkers for several diseases. In this study we surveyed the skin proteome qualitatively using gel
electrophoresis, liquid chromatography tandem mass spectrometry (GeLC-MS/MS) and quantitatively using an isobaric
tagging strategy (iTRAQ) to characterise the response of human skin following exposure to sodium dodecyl sulphate (SDS).
Results: A total of 653 skin proteins were assigned, 159 of which were identified using GeLC-MS/MS and 616 using iTRAQ,
representing the most comprehensive proteomic study in human skin tissue. Statistical analysis of the available iTRAQ data
did not reveal any significant differences in the measured skin proteome after 4 hours exposure to the model irritant SDS.
Conclusions: This study represents the first step in defining the critical response to an irritant at the level of the proteome
and provides a valuable resource for further studies at the later stages of irritant exposure.
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Introduction
Skin is the largest and most extensive organ in the human body,
accounting for some 15% of total body weight and fulfilling a
number of diverse functions. Importantly, it represents a major
barrier protecting the body from physical, chemical and microbial
impacts. With its ability to generate both innate and adaptive
immune responses, the skin forms an essential part of the immune
system [1]. As a primary defence organ, it is also involved in
thermoregulation, transduction of sensory information, protection
from UV radiation and dehydration as well as vitamin production
[2–4].
The functional diversity of skin is reflected in its complex
architecture and differentiation. The uppermost layer, the
epidermis, is separated by a basal membrane from the inner
layer, the dermis. While the dermis is composed of well
vascularised dense fibro-elastic connective tissue, the epidermis is
an avascular stratified squamous epithelium containing four
distinct cell types, principally keratinocytes, but also melanocytes,
Langerhan cells and Merkel cells [5]. During terminal differen-
tiation, keratinocytes produce keratin intermediate filaments,
which are cross-linked by transglutaminases. Keratinocytes
undergo apoptosis resulting in the characteristic cornified epider-
mis [6]. Skin additionally contains a variety of structures, such as
hair follicles, sweat and sebaceous glands, that traverse both layers.
During pathological processes major changes in the cellular
composition of skin can occur; for example, infiltration by a large
number of normally non-resident cells (neutrophils, eosinophils,
natural killer cells) during inflammation.
At the molecular level our understanding of the essential
physiological functions of skin, and in particular the qualitative
and quantitative changes of the proteome induced by exposure to
chemicals, is currently incomplete. Pioneering studies by Celis and
co-workers have identified a large number of proteins from
cultured human and mouse keratinocytes [7]. Additionally, studies
in sodium dodecyl sulphate (SDS) induced irritation/inflammation
of skin have revealed potential markers and hence provide a good
starting point for larger, quantitative studies into this and other
skin conditions [8,9]. Our ultimate goal is to use proteomic
approaches to investigate skin responses to chemical exposure.
Studying the changes in inflammatory, allergic and other
toxicological processes that are triggered in such circumstances
may shed light on the molecular processes associated with
particular pathologies. We are particularly interested in under-
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standing types and relative levels of nucleophilic amino acids in
proteins expressed in skin (‘nucleophilic make-up’), as well as
changes induced following topical application of chemicals.
Nucleophiles are key targets for covalent modification by reactive
chemicals (or reactive metabolites). These conjugation events
generate macromolecular immunogens as the small chemicals are
invisible to the immune system on their own. It is this event that
has long been postulated as causative of skin allergy [10–12].
Qualitative and quantitative insights into skin proteome and its
‘nucleophilic make-up’ may lead to a more physiologically relevant
interpretation of in chemico reactivity data [13].
In this paper we describe a survey of the skin proteome together
with an analysis of proteome changes induced by relatively short
exposure to the well characterised irritant SDS. Following
optimisation of conditions that allowed the rapid solubilisation of
skin, proteins from human biopsy samples were analysed by gel
electrophoresis, liquid chromatography tandem mass-spectrome-
try (GeLC-MS/MS) [14,15] and by the isobaric tagging strategy,
iTRAQ [16]. In the former method proteins are separated by
conventional 1-D gel electrophoresis prior to in situ trypsin
treatment. The resulting tryptic peptides are recovered, separated
by nano-scale liquid chromatography (nano-LC), and identified by
tandem MS and database searching. In the second approach,
tryptic peptides are labelled at their primary amines with specific
isobaric tags. The labelled peptides are then combined, fraction-
ated, and identified by tandem MS. As the isobaric tags release
reporter ions into a region of the mass spectrum that is chemically
silent with respect to amino acids and peptides, it is also possible to
obtain quantitative information on the peptides and hence the
proteins from which they originate. A large number of skin
components were uncovered and included keratins, heat shock
proteins, proteases, some constituents of adhesion complexes
specifically expressed during cornification and proteins involved in
the oxidative stress response. We further explore the skin proteome
qualitatively and quantitatively to obtain a thorough understand-
ing of the types and relative levels of key nucleophilic amino acids,
which could be potential targets for covalent modification
(haptenation) by chemical allergens [10–12]. To our knowledge,
this study represents the most comprehensive quantitative
proteomic survey of human skin to date.
Methods
Ethics Statement
Ethics was approved for this study (study number: 36-DRM-
BPY-06-001) by the Independent Ethics Committee of 4Front
Research (from 4th Dec 2006 for 1 year). All participants provided
written informed consent and sample collection was conducted
according to the principles expressed in the Declaration of
Helsinki.
Sample preparation
Sample Collection. Human skin samples (40–52 mg of
tissue) from various body sites, used for the method optimisation
and for surveying the skin proteome via GeLC-MS/MS, were
obtained with informed consent from patients attending derma-
tology clinics at the Royal South Hants Hospital, UK. Samples
were snap frozen in liquid nitrogen within 5 minutes of resection
and stored at 280uC prior to analysis.
For the quantitative proteomic analysis, skin biopsy samples
were collected by 4-Front Research (Manchester) from healthy
volunteers after exposure to the model irritant SDS. Ethical
approval was granted for this study and volunteers gave informed
written consent. 2–5% SDS (Sigma-Aldrich) in water, or a water-
only control, was applied to 18 mm Hill Top chambers, which
were applied to the volar forearm of 35 male volunteers for
4 hours. The exact concentrations of SDS that were applied to the
forearms of the volunteers can be found in Table S1 in File S1.
The precise concentration was determined during initial screening
and was the minimum that gave an ongoing erythematous
response. Erythema reactions were assessed, as described in
Basketter et al. [32], 1 hour after patch removal prior to 4 mm
punch biopsies being taken from the SDS-treated and control
(water-treated) sites.
Maceration of tissue samples. Biopsy samples were
washed twice with 500 ml of 50 mM triethylammonium bicarbon-
ate buffer (TEAB) to remove excess blood and placed into pre-
chilled tubes containing ceramic lysing beads (Matrix D –
QbioGene, Cambridge, UK) and 400 ml of the appropriate buffer.
Five solubilisation buffers were compared, with the following
compositions: Buffer 1 (0.5% Nonidet P-40, 0.5% sodium
deoxycholate, 10 mM EDTA in 100 mM TEAB); Buffer 2 (7 M
Urea, 2 M thiourea, 0.5% Amidosulfobetaine-14 in 100 mM
TEAB); Buffer 3 (7 M Urea, 2 M thiourea, 6 M guanidine HCl in
100 mM TEAB); Buffer 4 (0.1% Rapigest in 100 mM TEAB);
Buffer 5 (0.1% SDS in 100 mM TEAB). Each tube was then
processed using a Savant FastPrep macerator (Thermo Scientific,
Loughborough, UK) for 7 cycles of 45 seconds; speed setting 6.
The samples were chilled on ice for one minute between cycles
and centrifuged for 2 minutes at 9000 x g in a microcentrifuge after
cycle 3 and for 5 minutes at 9000 x g after cycle 7. The tissue lysate
was collected and the beads washed by adding 100 ml of the
selected buffer to the tube (containing the insoluble material),
vortexing for one minute and centrifuging for 2 minutes. The
supernatant and previously collected tissue lysate were pooled and
stored on ice prior to protein quantitation. The insoluble material
remaining after maceration was collected separately.
Estimation of protein concentration
The protein concentrations of the samples generated after
maceration using Buffers 1, 4 and 5 were determined using a
bicinchoninic acid (BCA) method [33,34], using a kit from Sigma-
Aldrich (Sigma, Poole, UK). Due to the incompatibility of urea
with the BCA assay, samples prepared in Buffers 2 and 3 were
determined using the Bradford assay (Bio-Rad, Hemel Hemp-
stead, UK).
GeLC-MS/MS studies
Following maceration, both soluble (40 mg) and insoluble skin
material were denatured in final sample buffer containing 10 mM
dithiothreitol at 70uC for 10 minutes. The denatured samples were
resolved in a NuPage 4–12% Bis-Tris gel (Invitrogen, Paisley, UK)
at 200 V for approximately 45 minutes. Following staining with
Colloidal Coomassie Blue, gel tracks (7 cm length) were excised,
cut into 25 equal-sized pieces and subjected to in situ trypsin
digestion using the method of Shevchenko et al [35]. The resulting
peptides were extracted and separated by nanocapillary liquid
chromatography (LC) prior to tandem mass spectrometry.
iTRAQ labelling
Isobaric tags for relative and absolute quantitation (iTRAQ)
produce MS/MS signature ions at m/z 114.1, 115.1, 116.1, and
117.1 (4-plex) with ions also at m/z 113.1, 118.1, 119.1 and 121.1
(8-plex) an area of the mass spectrum which has minimal
background noise, whilst the relative areas of these peaks
correspond with the proportions of the labeled peptides. This
approach allows the relative quantitation of expressed proteins
between either a maximum of 4 (4-plex) or 8 samples (8-plex)
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within a single experiment [16]. iTRAQ labelling of samples was
performed according to the manufacturer’s instructions (Applied
Biosystems, Warrington, UK).
To each of four samples containing ,150 mg of sample in #
34 ml of 0.5 M TEAB, 1 ml of 2% SDS and 2 ml of the reducing
agent, 50 mM (tris-(2-carboxyethyl) phosphine was added and
mixed. Samples were incubated at 60uC for 1 h. Methyl methane-
thiosulfonate in isopropanol (1 ml of 200 mM) was then added and
incubated for a further 10 min at room temperature. Proteins
were digested by adding 10 ml of 1 mg/ml trypsin in 80 mM
CaCl2. Samples were incubated for 16 h at 37uC.
Labelling of tryptic peptides with iTRAQ tags was achieved by
mixing the appropriate iTRAQ labelling reagent with the relevant
sample, and incubation at room temperature for 1 h or 2 h for the
4-plex and 8-plex tags, respectively. In the latter case, care was
taken to ensure the pH was ,7.5 by adding up to 5 ml of TEAB.
The main study was performed using the 4-plex iTRAQ tags
where the control and test samples from volunteer X were labelled
with isobaric tags 114 and 115, respectively, whereas, the control
and test samples obtained from volunteer Y were respectively
labelled with isobaric tags 116 and 117. The samples were then
combined and lyophilized in vacuo. As control and test samples
were obtained from 35 participants, seventeen 4-plex experiments
were prepared with control and test samples from two participants
and a final 2-plex experiment contained the control and test
sample from the 35th participant. For the reproducibility study, the
8-plex iTRAQ tags were used where the control and test samples
from volunteer F37 and F38 were labelled in duplicate.
Sample pre-processing prior to MS
The combined iTRAQ peptide mixtures were separated by
reverse phase chromatography using a Dionex Ultimate LC
system and Jupiter C18 reverse phase column (2.1 mm i.d., x
250 mm, 4 mm), (Phenomenex, Macclesfield, UK). Samples were
solubilised in 500 ml of Buffer A (5% (v/v) acetonitrile, 0.1%
formic acid) and loaded onto the column using a 500 ml loop. The
loaded sample was injected and washed with Buffer A for 20 min
at 200 ml/min to remove excess reagent. Peptides were eluted with
a linear gradient of 0–80% Buffer B (95% acetonitrile, 0.1%
formic acid) at 200 ml/min with fractions collected at 1 min
intervals. Peptide elution was monitored at 214, 235 and 280 nm.
Fractions were lyophilised in vacuo prior to MS analysis.
Mass spectrometry analysis
Peptide samples extracted from 1D-SDS PAGE of soluble and
insoluble skin material and iTRAQ labelled samples after the
sample pre-processing stage were subjected to MS analysis as
follows. 30 ml of 10% acetonitrile containing 0.1% formic acid was
added to each sample and loaded onto a reverse phase trap
column (5 mm6300 mm, i.d., Dionex, Camberley, UK). The
samples were washed for 10 minutes with buffer A prior to the
analytical nano-LC separation using a Pepmap C18 Reverse phase
column (3 mm, 150 mm675 mm, i.d., Dionex, Camberley, UK).
Fractions were separated over 120 min using a gradient of 0 to
80% Buffer B at 200 nl/min) and electrosprayed into the mass
spectrometer. All data were acquired using a Q-tof Global Ultima
(Waters Ltd, Manchester, UK) fitted with a nanoLockSpray
source. A survey scan was acquired from m/z 350 to 1700 with the
Figure 1. Cellular location of proteins identified from GeLC-MS/MS analysis of human skin. Locations of proteins identified in the GeLC-
MS/MS analysis of the soluble and insoluble fractions annotated to the GOA human GO slim terms and the Generic human GO slim terms for cellular
compartment, using GO Term Mapper (http://go.princeton.edu/cgi-bin/GOTermMapper). For comparison, the percentage proteins annotated to
these terms in the annotated human proteome is also shown.
doi:10.1371/journal.pone.0097772.g001
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switching criteria for MS to MS/MS including ion intensity and
charge state. The collision energy used to perform MS/MS was
varied according to the mass and charge state of the eluting
peptide.
The spectra generated in this study has been submitted to the
PRIDE database; Project Accession PRD000149 (to view please
use reviewer account username: review90658 and password:
WTYhPfPG).
Data analysis
Peak lists were generated using ProteinLynx Global Server 2.2.5
(Waters Ltd, Manchester, UK). The following parameters were
used for processing the MS/MS spectra; normal background
subtraction with a 25% background threshold and medium de-
isotoping with a threshold of 1%; no smoothing was performed.
Peak lists were submitted to the MASCOT search engine
version 2.2.1 (MatrixScience, London, UK) and the data searched
against a human NCBInr protein sequence database, containing a
total of 40877 protein sequences (accessed 10th May 2007). The
corresponding quantitative information using the iTRAQ reporter
ions, and incorporating isotope correction factors, was also
obtained via MASCOT.
Database searches allowed a maximum of one missed cleavage
for tryptic digestion while more specifically, for GeLC-MS/MS
data the allowed fixed and variable modifications were carboxy-
amidomethylation of cysteine and the oxidation of methionine,
respectively; for iTRAQ data fixed modifications for methyl
methane-thiosulfonation of cysteine and the N-terminus and lysine
side chains using either the 4-plex or 8-plex iTRAQ label were
allowed (Applied Biosystems, Warrington, UK). Variable modifi-
cation for the oxidation of methionine and iTRAQ modification of
tyrosine were also allowed. Precursor ion and sequence ion mass
tolerances were set at 100 ppm and 0.2 Da respectively. Protein
identifications required the assignment of $2 different peptides
with a significance threshold for accepting a match of p,0.05.
The protein ratios were calculated using MASCOT version 2.2.1,
where the peptide ratios were weighted and median normalisation
was performed, automatic outlier removal was chosen and the
peptide threshold was set to ‘at least homology’. False discovery
rates were calculated by running all spectra against a decoy
database using the MASCOT software, the false discovery rate
was invariably ,2.1%.
Gene Identifiers for the proteins, obtained after MASCOT
searching, were cross-referenced with UniProt identifiers using the
open-access Protein Identifier Cross Reference tool (http://www.
ebi.ac.uk/Tools/picr/), with searches limited to human proteins
and mapped to the Swiss-Prot and TrEMBL databases. Proteins
were further annotated with theoretical mass and pI information
(http://www.expasy.ch/tools/pi_tool.html), where Uniprot iden-
tifiers were not available, mass and pI were taken from the
MASCOT search data files.
Figure 2. Biological function of all proteins identified after mass spectrometry analysis of human skin. Biological processes associated
with proteins identified in human skin using GeLC-MS/MS and iTRAQ analyses. Proteins were annotated with the GOA human GO slim terms for
biological process, using GO Term Mapper (http://go.princeton.edu/cgi-bin/GOTermMapper). For comparison, the percentage proteins annotated to
these terms in the annotated human proteome is also shown.
doi:10.1371/journal.pone.0097772.g002
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Data integration, processing and statistical
analyses. Prior to formal statistical analysis, raw intensity values
were corrected for minor cross-channel isotope bias using
formulae supplied by Applied Biosystems, average intensities
calculated for each peptide across multiple queries, and proteins
removed that were identified by only one peptide. Data from
multiple iTRAQ experiments were then analysed using SAS v9.2
(SAS Institute Inc., Cary, NC, USA) using the modelling approach
of Hill et al. [36]. Intensities were transformed using log base 2 and
normalised using backfitting as suggested by Oberg et al. [37]. This
was implemented using an iterative fit to experimental and
protein/peptide imbalances with code originally authored by
Douglas W. Mahoney at the Mayo Foundations for Medical
Education and Research (see Supporting Information for the
Oberg paper).
Proteins identified in 5 or fewer individuals were removed from
the analysis, leaving 136 proteins. A general linear mixed model
was then applied to the normalised log-transformed intensities for
each protein in turn, with the two-level factor treatment/control as
the only fixed explanatory effect, and a single random effect
(individual*treatment) to model the within-individual correlations
of the peptides. The addition of the random effect in this analysis
also ensures that an appropriate number of degrees of freedom is
used in the statistical test for treatment vs. control and therefore
avoids ‘‘spurious accuracy’’ in the results. Estimates and 95% C.I.s
for the difference between treatment and control were produced
from the model and back-transformed from the log-scale to a ratio
(treatment/control) scale. P-values were output and a Bonferroni
correction applied.
Gene ontology analysis. Uniprot identifiers from the GeLC-
MS/MS and iTRAQ experiments were submitted into Gene
Ontology (GO) Term Mapper (http://go.princeton.edu/cgi-bin/
GOTermMapper) and were searched against the goa_human
(GOA GO slim) and the goa_human (Generic GO slim) terms for
cellular compartment and biological process. The most relevant
terms were taken from the GOA and Generic GO slim searches
and combined into one file. The numbers of proteins annotated to
each term are expressed as a percentage of the total number of
Uniprot identifiers submitted into the GO Term Mapper.
Estimation of nucleophilic abundance within the
identified skin proteome. Quantification of nucleophilic
abundance was performed according to the calculations described
by Ishihama et al [38]. This work applies the emPAI (Exponen-
tially Modified Protein Abundance Index) value for a population
of proteins identified through mass spectrometry to estimate their
absolute abundance within a sample. The emPAI value is a
derivation of the total number of observed peptides per protein
divided by the total number of observable peptides per protein.
The emPAI values used here were calculated in Mascot (ver 2.2)
per experiment, representing two patients, and converted to
protein weight fraction, as described in equation 1 [38]. Based on
measurements from section 2.2 (,50 mg protein per mg skin), the
weight fraction was converted to absolute weight per mg skin tissue
(equation 2). This was then converted to moles per mg tissue
(equation 3) and copy number of each protein (equation 4).
For each protein, FASTA sequences were downloaded from
UniProt (where available) and NCBI Protein, via their respective
webservices [39,40]. A computational approach was used to count
the nucleophilic residues, Arg, Cys, His, Lys and Tyr within each
Figure 3. Plot of protein abundance versus abundance ranking. Estimated copy numbers for identified proteins. The steep gradient gives
confidence that the most significant members of the skin protein population have been identified. The most prevalent proteins were shown to be in
the Keratin family, as expected.
doi:10.1371/journal.pone.0097772.g003
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sequence. Nucleophile counts were multiplied by copy number,
summed and proportions of each were compared against the non-
nucleophilic residues. Additionally, where information on disul-
phide-bridged Cys residues was available from UniProt, this was
subtracted from the sum of available nucleophiles. Results for
Haemoglobin and Serum Albumin proteins were removed from
the final analysis as these were believed to be present as a result of
the skin biopsy procedure.
Equation 1: Protein content (weight fraction),
P1 =
emPAI MW
P
(emPAI MW )
Equation 2: mg protein per mg tissue, P2 = P1650* (*,50 mg
protein per mg skin)
Equation 3: Moles protein per mg tissue, P3 =
P2
106
6MW
Equation 4: Number of proteins per mg tissue = P36A (mean
taken across 18 iTRAQ experiments with emPAI values)
Where MW = molecular weight and A=Avogadro’s constant,
6.022141561023
Results
An optimised, iTRAQ-compatible method for solubilising
skin proteins
It was first necessary to devise an efficient procedure for the
solubilisation of skin components that would be compatible with
quantitative proteomic procedures such as iTRAQ. Proteins were
extracted from human skin biopsy samples by maceration using a
ceramic bead beating system and the degree of protein solubili-
sation was optimised using buffers containing different combina-
tions of detergents and chaotropic agents. The amount of protein
extracted per milligram of tissue was similar for all five buffers
used, although Buffers 4 and 5 gave the least and most solubilised
protein, respectively (Table S2 in File S1). Buffers 2 and 3
solubilised proteins with a wide range of molecular weights but left
a significant number of proteins behind in the insoluble material.
Buffers 4 and 5 solubilised a range of proteins and produced a
good range of bands in both the high and low molecular weight
regions of 1-D gels (Figure S1 in File S2). However, the
intensities of individual bands were greater with Buffer 5.
To evaluate the compatibility of the solubilisation buffers with
quantitative proteomic strategies such as iTRAQ, equal amounts
of solubilised skin proteins prepared in the Buffers 2, 3, 4 and 5
were labelled with iTRAQ tags 114, 115, 116 and 117,
respectively, under standard conditions. (Samples solubilised with
Buffer 1 were not studied further as it was likely that the NP-40
detergent contained in the buffer would interfere with the
processing for MS analysis). Labelled samples were combined
and analysed using data-dependent LC-MS/MS. Inspection of the
fragmentation spectra indicated that the ion counts for the 117
isobaric tag were generally higher than the average ion counts for
the other tags (data not shown). Thus, the data suggest that Buffer
Figure 4. Estimated ratio of non-nucleophiles to nucleophiles with the identified skin proteins. Sequences for proteins identified from
the skin biopsy samples were scanned for nucleophilic residues, Cys, His, Lys, Tyr & Arg, and counts were adjusted for protein abundance, which was
calculated using emPAI values [38]. Results showed the ratio of non-nucleophiles to nucleophiles to be ,83:17
doi:10.1371/journal.pone.0097772.g004
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5 (0.1% SDS in 100 mM TEAB) provided the best quality mass
spectra and was optimal for solubilisation of proteins from skin
biopsy samples. Accordingly, this buffer was used for subsequent
GeLC-MS/MS and iTRAQ studies.
Qualitative survey of the human skin proteome
In view of the paucity of information on the global protein
composition of skin, a shotgun proteomics study was carried out to
survey the human skin proteome. Conventional SDS-PAGE in
conjunction with nanocapillary LC and MS/MS (GeLC-MS/MS)
was used to increase the peptide peak and load capacity, thereby
increasing the number of components that could be identified.
Both the soluble fraction and insoluble fractions obtained from the
processing of skin in 0.1% SDS+100 mM TEAB were subjected to
GeLC-MS/MS. A comparison of the proteins identified in both
fractions in relation to the Gene Ontology terms for cellular
compartment revealed that a wide range of proteins were
solubilised, including cytoplasmic, cytoskeletal, membrane and
extracellular proteins (Fig 1). The GeLC-MS/MS dataset was
combined with qualitative data from 18 iTRAQ experiments,
described in the next section, to maximise coverage of the skin
proteome. In all, GeLC-MS/MS and iTRAQ approaches
identified 159 and 616 proteins, respectively, of which 122 were
common to both. Of the 159 proteins identified in the GeLC-MS/
MS studies, 64 and 51 were found exclusively in the insoluble and
soluble fractions, respectively. Collectively, the proteins that were
revealed had diverse physico-chemical properties suggesting that
the sampling strategy was relatively unbiased. For example, the
molecular masses of the identified proteins ranged from 11–
165 kDa in the soluble fraction and from 10–513 kDa in the
insoluble residue; their predicted isoelectric points (pIs) ranged
from 4.1 to 10.1 in the soluble fraction and from 4.7 to 11.4 in the
insoluble residue. Thus, the method developed for the preparation
of skin biopsy samples yielded an acceptable range of proteins that
were likely to be representative of the expressed skin proteome.
A list of the proteins identified in both the GeLC-MS/MS and
iTRAQ studies is shown in Table S3 in File S1. In keeping with
their role in maintaining tissue integrity, a variety of keratins were
uncovered, including keratins 1–10, 12–20 and 24–25. All of the
keratins were identified in the iTRAQ studies, although many
were also associated with the insoluble fraction from the GeLC-
MS/MS analysis. Several proteases were identified, including
caspase-14 (expression of which was validated by western blot
analysis, see Figure S2 in File S2), which is involved in filaggrin
processing [17,18], cathepsins D and G, chymase I, carboxypep-
tidase A3 and tryptase. A number of heat shock proteins (HSPs)
were identified, including HSP27, the expression of which has
previously been found altered upon SDS exposure in human
keratinocytes and excised skin [19,20]. Constituents of the
adhesion complexes specifically expressed during cornification
(e.g. periplakin, plakophilin, desmoglein and desmocollin) were
observed as well as proteins involved in anti-oxidant defense (e.g.
catalase, superoxide dismutase, peroxiredoxin and thioredoxin)
[6,21]. Our analyses showed that skin contains several members of
the 14-3-3 family of proteins (e.g. YWHAB, YWHAE, YWHAG,
YWHAH, YWHAQ and YWHAZ), which mediate signal
transduction by binding to phosphoserine-containing proteins.
The molecular rationale for the diversity of such proteins in skin
awaits further investigation. Gene Ontology annotations of the
proteins identified in the GeLC-MS/MS and iTRAQ experiments
for terms associated with biological processes revealed that
collectively there is no bias in the types of proteins identified
Figure 5. Summary of all proteins, and false discovery rates, identified within each iTRAQ 4-plex experiment. The number of proteins
identified in skin samples from different volunteers following MASCOT searches of the NCBI non-redundant human database, including the number
of proteins that also had quantitative data associated with each participant. The graph also indicates the number of proteins that yielded quantitative
data and the false discovery rates for each experiment, as determined by searching the reverse NCBI non-redundant human database.
doi:10.1371/journal.pone.0097772.g005
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using either GeLC-MS/MS or iTRAQ approaches. The skin
proteome appears to contain components involved in a number of
different biological processes, including regulatory processes,
transport and metabolism (Fig 2).
The most abundant proteins observed in our samples were
members of the keratin family, with an estimate in the region of
1013 molecules per mg skin. Haemoglobins and Serum Albumin
were present at orders of magnitude higher than the keratins
however these were removed from the final calculation as they
were believed to be due to blood contamination of the skin samples
from the biopsy process. The proteins that could not be
confidently identified by mass spectrometry in these samples could
potentially affect the calculations of nucleophilic abundance.
However, plotting identified protein abundance versus abundance
ranking gives reassurance that a representative population of
proteins have been accounted for (Fig 3). The estimated ratio of
non-nucleophiles to nucleophiles in the skin was found to be in the
region of 83:17 (Fig 4). The proportions of nucleophiles break
down into Lys 5.7%, Arg 5.5%, Tyr 3.1%, His 1.5% and Cys not
involved in disulphide bridges 0.9%. Total nucleophile propor-
tions were similar in subcellular locations: extracellular 17.8%;
membrane, 17.1%: cytoplasm, 17.5%; nucleus, 17.9%.
Results compare well with Cedano et al [22], in which 1200
sequences from different subcellular locations were surveyed for
residue content. These results follow a similar trend before
adjustment for protein abundance and disulphide-bridging. We
also surveyed the nucleophilic content from other tissue types as
annotated in UniProt. These studies suggest that abundance of key
nucleophilic amino acids in skin is comparable to the human
proteome overall.
iTRAQ analysis
To complement the shotgun proteomic studies, an iTRAQ
analysis was undertaken to compare alterations in protein
expression 4 hours after SDS treatment. The spectra generated
in this study were been submitted to the PRIDE database; Project
Accession PRD000149.
The total number of proteins identified in each of the 18
experiments, representing 35 individuals, varied from 48 to 222,
with false discovery rates of #2.1% (Fig 5). By combining the
search data from all 18 experiments, a total of 405,054 mass
spectra led to the identification of 24,581 peptides, which were
assigned to 616 proteins; quantitative data in at least one
experiment was obtained for 367 of these proteins. Reproducibil-
ity, as assessed by separate analysis of the same samples using 8-
plex iTRAQ gave very similar ratio values for the majority of those
proteins identified in both the original 4-plex iTRAQ and the 8-
plex iTRAQ experiments (Figure S3 in File S2). A list of
identified proteins, together with their calculated expression ratios
in SDS-treated and untreated skin, is shown in File S3.
As expected, only modest changes in protein expression were
observed following 4 h exposure of skin to SDS, with coefficients
of variation for the protein ratios ranging from 0.3%–234% and
an average value of 23.5%. However, robust statistical analysis
using ANOVA revealed that these changes were not significant,
although several proteins showed trends toward up-regulation.
Discussion
Stratified epithelia cover the entire external and internal
surfaces of the human body and serve to prevent water loss as
well as to protect against chemical damage, environmental insults
and infection. Despite these crucial roles, relatively little is known
about the global protein composition of skin and how it changes in
response to exposure to noxious substances. In this paper, we have
reported an efficient method for solubilisation of skin proteins and
its use to conduct a detailed survey of the skin proteome and to
study early responses to the irritant SDS.
The new method identified a diversity of proteins, with a broad
range of molecular weights and isoelectric points (pIs), from many
sub-cellular locations (cytoskeletal-, extracellular-, nuclear-, and
membrane-associated etc.). These observations suggest that the
skin proteome is sampled in a relatively unbiased manner.
Furthermore, the relative speed of the new procedure, coupled
with its ability to process multiple samples in parallel, allows
rigorous and statistically robust clinical proteomic studies on skin.
Previously, proteomic analysis of corneocytes obtained by
varnish stripping normal skin identified 77 proteins [23]. In two
separate studies, Broccardo et al performed LC-MS/MS analysis
of lysates of skin cells sampled by tape stripping acute and chronic
lesional and non-lesional areas in patients with atopic dermatitis as
well as non-atopic individuals and identified 104 and 153 proteins
[24,25]. Using the present method, a survey of human skin
proteome, using both GeLC-MS/MS and iTRAQ approaches, we
identified 653 proteins, with 39, 69 and 100 proteins overlapping
with the studies described above, respectively. While the total
repertoire of skin proteins is undoubtedly larger, the identified
peptides and proteins provide a framework for further targeted
studies. For example, it should now be possible to measure in
parallel the levels of all 653 proteins under different cellular
conditions using multiple (or selected) reaction monitoring [26].
Further, an extension of this approach can be used to quantify
reversible post-translation modifications of these proteins, e.g.
phosphorylation, as well as irreversible modifications such as
haptenation. The data can also be used to aid deeper mining of the
skin proteome. For example, knowledge of the relative abundance
of the proteins (as indicated by the number of times that their
peptides were sampled during the study), allows the design of
better strategies for the depletion of common proteins, thereby
allowing low abundance proteins to be uncovered.
In this study we also investigated changes in the skin proteome
during the early irritant responses of skin to SDS using an iTRAQ
strategy. Relatively few differentially expressed proteins were
uncovered as the skin biopsies were taken 1 hour after 4 hours of
treatment with SDS, however analysis by ANOVA revealed that
these changes were not statistically significant. The co-efficient of
variation of the protein ratios ranged from 0.3%–234.4% resulting
in a relatively low magnitude of the fold-changes.
This dataset is additionally providing a valuable insight into
levels of key protein nucleophilic residues that are potential
conjugation targets of electrophilic chemicals or metabolites, the
products of which are causative of a variety of adverse effects, most
notably delayed type hypersensitivity reactions [10–12]. However,
current understanding of chemical conjugation to proteins dictates
that actual covalent modifications occur only on a small
proportion of total protein nucelophiles. Information obtained
from studies using single protein models [27–31] showed that
chemical modification of proteins only occurs in the specific
microenvironments within the 3D protein structures which are
especially conducive to reactivity, via the influence of the
neighbouring side chains on the pKa of the target nucleophiles.
Thus more effort is required to account for the role of the 3D
protein structure in determining the ultimate availability of
nucleophilic amino acid side chains for reaction with exogenous
chemical in physiologically relevant conditions. It is important to
note that this dataset does not include non-protein nucleophiles
that are normally present in all tissues including skin (e.g.
glutathione (GSH)), which will contribute to the overall conjuga-
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tion reactions of the exogenous chemical but will not generate
immunogenic species. Understanding not only the nucleophilic
make-up of skin tissue but also the effective availability of
nucleophiles for conjugation with chemicals will be instrumental
in understanding the formation of complete antigens in human
skin and their inherent immunogenicity in delayed type hyper-
sensitivity. This information may also help interpretation of
chemical reactivity data obtained using simple models of protein
nucleophiles in a physiological context [13].
Conclusions
We have produced the most comprehensive qualitative and
quantitative dataset of skin proteome to date and characterised
early responses to the irritant SDS at the level of the proteome.
Additionally, we used this dataset to investigate types and relative
levels of key nucleophilic amino acids, potential targets for
haptenation by chemicals. These studies should provide a
framework for future investigations to further define critical
properties of skin, and in particular its responses to noxious agents.
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showing expression of caspase-14. Figure S3 Reproducibility of
data in a representative experiment (F37F38) using 4- and 8-plex
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